{"url_path":"/sec/vcel/8-k/2026-05-18/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/887359/0001140361-26-021892-index.html","accession_number":"0001140361-26-021892","cik":"0000887359","ticker":"VCEL","issuer_name":"Vericel Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/887359/0001140361-26-021892-index.html","primary_entity_key":"0000887359","primary_entity_name":"Vericel Corp"},"word_count":102,"has_tables":true,"body_markdown":"Item 5.03\n\nAmendments to Articles of Incorporation or Bylaws.\n\nEffective May 18, 2026, the Board of Directors of Vericel Corporation, a Michigan\ncorporation (the “Company”), approved an amendment to the Company’s bylaws. The amendment accounts for the change in the address of the Company’s principal executive offices as a result of its move to a new global headquarters, located at 25\nBlue Sky Drive, Burlington, Massachusetts 01803.  This description is qualified in its entirety by reference to the text of the Second Amended and Restated Bylaws of Vericel Corporation filed as Exhibit 3.1 to this Report, which is incorporated\nherein by reference."}